180 related articles for article (PubMed ID: 11987320)
1. Type 1 diabetes: benefits of intensive insulin therapy. Patients should control blood glucose strictly.
Prescrire Int; 2002 Apr; 11(58):61. PubMed ID: 11987320
[TBL] [Abstract][Full Text] [Related]
2. Glucose evaluation trial for remission (GETREM) in type 1 diabetes: a European multicentre study.
Pozzilli P; Manfrini S; Buzzetti R; Lampeter E; Leeuw ID; Iafusco D; Prisco M; Ionescu-Tirgoviste C; Kolouskovà S; Linn T; Ludvigsson J; Madàcsy L; Mrozikiewicz AS; Mrozikiewicz PM; Podar T; Vavrinec J; Vialettes B; Visalli N; Yilmaz T; Browne PD;
Diabetes Res Clin Pract; 2005 Jun; 68(3):258-64. PubMed ID: 15936469
[TBL] [Abstract][Full Text] [Related]
3. [Insulin treatment in type 2 diabetes: epidemiological data].
Papoz L
Diabetes Metab; 2001 Nov; 27(5 Pt 3):S7-14. PubMed ID: 11910979
[TBL] [Abstract][Full Text] [Related]
4. Deleterious effects of increased body weight associated with intensive insulin therapy for type 1 diabetes: increased blood pressure and worsened lipid profile partially negate improvements in life expectancy.
Palmer AJ; Roze S; Valentine WJ; Minshall ME; Lammert M; Nicklasson L; Spinas GA
Curr Med Res Opin; 2004 Aug; 20 Suppl 1():S67-73. PubMed ID: 15324518
[TBL] [Abstract][Full Text] [Related]
5. Insulin therapy in Europe.
Scherbaum WA
Diabetes Metab Res Rev; 2002; 18 Suppl 3():S50-6. PubMed ID: 12324986
[TBL] [Abstract][Full Text] [Related]
6. Intensive insulin regimens: evidence for benefit.
Bretzel RG
Int J Obes Relat Metab Disord; 2004 Sep; 28 Suppl 2():S8-13. PubMed ID: 15306832
[TBL] [Abstract][Full Text] [Related]
7. Intensive insulin therapy in insulin-dependent diabetes mellitus, the results of the diabetes control and complications trial.
Duron F
Biomed Pharmacother; 1995; 49(6):278-82. PubMed ID: 7579008
[TBL] [Abstract][Full Text] [Related]
8. An update on the long-acting insulin analogue glargine.
Thisted H; Johnsen SP; Rungby J
Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):1-11. PubMed ID: 16867163
[TBL] [Abstract][Full Text] [Related]
9. Unlocking the opportunity of tight glycaemic control. Far from goal.
Del Prato S
Diabetes Obes Metab; 2005 Nov; 7 Suppl 1():S1-4. PubMed ID: 16135133
[TBL] [Abstract][Full Text] [Related]
10. Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria.
Schütt M; Kern W; Krause U; Busch P; Dapp A; Grziwotz R; Mayer I; Rosenbauer J; Wagner C; Zimmermann A; Kerner W; Holl RW;
Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):384-8. PubMed ID: 16915542
[TBL] [Abstract][Full Text] [Related]
11. Glycaemic control with modified intensive insulin injections (MII) using insulin pens and premixed insulin in children with type-1 diabetes: a randomized controlled trial.
Soliman AT; Omar M; Rizk MM; El Awwa A; AlGhobashy FM
J Trop Pediatr; 2006 Aug; 52(4):276-81. PubMed ID: 16410276
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial of Sweet Talk, a text-messaging system to support young people with diabetes.
Franklin VL; Waller A; Pagliari C; Greene SA
Diabet Med; 2006 Dec; 23(12):1332-8. PubMed ID: 17116184
[TBL] [Abstract][Full Text] [Related]
13. Improved glycaemic control of thrice-daily biphasic insulin aspart compared with twice-daily biphasic human insulin; a randomized, open-label trial in patients with type 1 or type 2 diabetes.
Clements MR; Tits J; Kinsley BT; Råstam J; Friberg HH; Ligthelm RJ
Diabetes Obes Metab; 2008 Mar; 10(3):229-37. PubMed ID: 18269638
[TBL] [Abstract][Full Text] [Related]
14. Inhaled human insulin ((insulin human [rDNA origin]) Inhalation Powder) in diabetes mellitus.
Mathieu C
Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):779-91. PubMed ID: 17014394
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of insulin detemir in clinical practice: 14-week follow-up data from type 1 and type 2 diabetes patients in the PREDICTIVE European cohort.
Dornhorst A; Lüddeke HJ; Sreenan S; Koenen C; Hansen JB; Tsur A; Landstedt-Hallin L
Int J Clin Pract; 2007 Mar; 61(3):523-8. PubMed ID: 17313628
[TBL] [Abstract][Full Text] [Related]
16. Insulin lispro improves postprandial glucose control in patients with diabetes mellitus.
Skrha J; Smahelová A; Andĕl M; Vrtovec M; Subić J; Kreze A; Vozar J; Korecová M; de Verga V; Wyatt J; Metcalfe S; Ristić S
Sb Lek; 2002; 103(1):15-21. PubMed ID: 12448933
[TBL] [Abstract][Full Text] [Related]
17. The Scylla and Charybdis of blood glucose control in children with diabetes mellitus.
Sperling MA
J Pediatr; 1997 Mar; 130(3):339-41. PubMed ID: 9063403
[No Abstract] [Full Text] [Related]
18. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A
Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus.
Yki-Järvinen H
Diabetes Metab Res Rev; 2002; 18 Suppl 3():S77-81. PubMed ID: 12324990
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance is associated with microangiopathy in type 1 diabetic patients treated with intensive insulin therapy from the onset of disease.
Uruska A; Araszkiewicz A; Zozulinska-Ziolkiewicz D; Uruski P; Wierusz-Wysocka B
Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):478-84. PubMed ID: 20373280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
